|
1
|
Mroczko B and Szmitkowski M:
Macrophage-colony stimulating factor (M-csf) in diagnostic and
monitoring of non-small-cell lung cancer (NSCLC). Pol Arch Med
Wewn. 105:203–209. 2001.(In Polish). PubMed/NCBI
|
|
2
|
Aharinejad S, Paulus P, Sioud M, Hofmann
M, Zins K, Schäfer R, Stanley ER and Abraham D: Colony-stimulating
factor-1 blockade by antisense oligonucleotides and small
interfering RNAs suppresses growth of human mammary tumor
xenografts in mice. Cancer Res. 64:5378–5384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ding J, Guo C, Hu P, Chen J, Liu Q, Wu X,
Cao Y and Wu J: CSF1 is involved in breast cancer progression
through inducing monocyte differentiation and homing. Int J Oncol.
49:2064–2074. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Scholl SM, Pallud C, Beuvon F, Hacene K,
Stanley ER, Rohrschneider L, Tang R, Pouillart P and Lidereau R:
Anti-colony-stimulating factor-1 antibody staining in primary
breast adenocarcinomas correlates with marked inflammatory cell
infiltrates and prognosis. J Natl Cancer Inst. 86:120–126. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chockalingam S and Ghosh SS: Amelioration
of cancer stem cells in macrophage colony stimulating
factor-expressing U87MG-human glioblastoma upon 5-fluorouracil
therapy. PLoS One. 8:e838772013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paulus P, Stanley ER, Schäfer R, Abraham D
and Aharinejad S: Colony-stimulating factor-1 antibody reverses
chemoresistance in human MCF-7 breast cancer xenografts. Cancer
Res. 66:4349–4356. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharma S, Patnaik PK, Aronov S and
Kulshreshtha R: Apoptomirs of breast cancer: Basics to clinics.
Front Genet. 7:1752016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schmid T, Zhou J and Brune B: HIF-1 and
p53: Communication of transcription factors under hypoxia. J Cell
Mol Med. 8:423–431. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang GL, Jiang BH, Rue EA and Semenza GL:
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS
heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci
USA. 92:5510–5514. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang C, Samanta D, Lu H, Bullen JW, Zhang
H, Chen I, He X and Semenza GL: Hypoxia induces the breast cancer
stem cell phenotype by HIF-dependent and ALKBH5-mediated
m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA.
113:E2047–E2056. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin SC, Liao WL, Lee JC and Tsai SJ:
Hypoxia-regulated gene network in drug resistance and cancer
progression. Exp Biol Med. 239:779–792. 2014. View Article : Google Scholar
|
|
12
|
Nieminen AL, Qanungo S, Schneider EA,
Jiang BH and Agani FH: Mdm2 and HIF-1alpha interaction in tumor
cells during hypoxia. J Cell Physiol. 204:364–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lehman JA, Hauck PM, Gendron JM, Batuello
CN, Eitel JA, Albig A, Kadakia MP and Mayo LD: Serdemetan
antagonizes the Mdm2-HIF1α axis leading to decreased levels of
glycolytic enzymes. PLoS One. 8:e747412013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan EY, Campo L, Han C, Turley H, Pezzella
F, Gatter KC, Harris AL and Fox SB: BNIP3 as a progression marker
in primary human breast cancer; Opposing functions in in situ
versus invasive cancer. Clin Cancer Res. 13:467–474. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siddiqui WA, Ahad A and Ahsan H: The
mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update.
Arch Toxicol. 89:289–317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan C, Pu L, He Z and Wang J:
BNIP3/Bcl-2-mediated apoptosis induced by cyclic tensile stretch in
human cartilage endplate-derived stem cells. Exp Ther Med.
15:235–241. 2018.PubMed/NCBI
|
|
17
|
Zhao L, Man Y and Liu S: Long non-coding
RNA HULC promotes UVB-induced injury by up-regulation of BNIP3 in
keratinocytes. Biomed Pharmacother. 104:672–678. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Decker KF, Zheng D, Matkovich SJ,
Jia L and Dorn GW II: A nucleus-targeted alternately spliced
Nix/Bnip3L protein isoform modifies nuclear factor κB
(NFκB)-mediated cardiac transcription. J Biol Chem.
288:15455–15465. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Graham RM, Thompson JW and Webster KA:
Inhibition of the vacuolar ATPase induces Bnip3-dependent death of
cancer cells and a reduction in tumor burden and metastasis.
Oncotarget. 5:1162–1173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang M, Zhang H, Tang F, Wang Y, Mo Z,
Lei X and Tang S: Doxorubicin resistance mediated by cytoplasmic
macrophage colony-stimulating factor is associated with switch from
apoptosis to autophagic cell death in MCF-7 breast cancer cells.
Exp Biol Med. 241:2086–2093. 2016. View Article : Google Scholar
|
|
21
|
Douzono M, Suzu S, Yamada M, Yanai N,
Kawashima T, Hatake K and Motoyoshi K: Augmentation of cancer
chemotherapy by preinjection of human macrophage colony-stimulating
factor in L1210 leukemic cell-inoculated mice. Jpn J Cancer Res.
86:315–321. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Global Burden of Disease Cancer
Collaboration, ; Fitzmaurice C, Allen C, Barber RM, Barregard L,
Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R,
Dandona L, et al: Global, Regional, and national cancer incidence,
mortality, years of life lost, years lived with disability, and
disability-adjusted life-years for 32 cancer groups, 1990 to 2015:
A systematic analysis for the global burden of disease study. JAMA
Oncol. 3:524–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morry J, Ngamcherdtrakul W, Gu S, Reda M,
Castro DJ, Sangvanich T, Gray JW and Yantasee W: Targeted treatment
of metastatic breast cancer by PLK1 siRNA delivered by an
antioxidant nanoparticle platform. Mol Cancer Ther. 16:763–772.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Parvani JG and Jackson MW: Silencing the
roadblocks to effective triple-negative breast cancer treatments by
siRNA nanoparticles. Endocr Relat Cancer. 24:R81–R97. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Cai L, Wang H, Wu P, Gu W, Chen Y,
Hao H, Tang K, Yi P, Liu M, et al: Pleiotropic regulation of
macrophage polarization and tumorigenesis by formyl peptide
receptor-2. Oncogene. 30:3887–3899. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qian BZ and Pollard JW: Macrophage
diversity enhances tumor progression and metastasis. Cell.
141:39–51. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pollard JW: Tumour-educated macrophages
promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78.
2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Behnes CL, Bremmer F, Hemmerlein B,
Strauss A, Ströbel P and Radzun HJ: Tumor-associated macrophages
are involved in tumor progression in papillary renal cell
carcinoma. Virchows Arch. 464:191–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kacinski BM, Scata KA, Carter D, Yee LD,
Sapi E, King BL, Chambers SK, Jones MA, Pirro MH and Stanley ER:
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are
expressed by human breast carcinomas in vivo and in vitro.
Oncogene. 6:941–952. 1991.PubMed/NCBI
|
|
30
|
Ramakrishnan S, Xu FJ, Brandt SJ, Niedel
JE, Bast RC Jr and Brown EL: Constitutive production of macrophage
colony-stimulating factor by human ovarian and breast cancer cell
lines. J Clin Invest. 83:921–926. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kacinski BM, Carter D, Mittal K, Yee LD,
Scata KA, Donofrio L, Chambers SK, Wang KI, Yang-Feng T and
Rohrschneider LR: Ovarian adenocarcinomas express fms-complementary
transcripts and fms antigen, often with coexpression of CSF-1. Am J
Pathol. 137:135–147. 1990.PubMed/NCBI
|
|
32
|
Kacinski BM: CSF-1 and its receptor in
ovarian, endometrial and breast cancer. Ann Med. 27:79–85. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mroczko B, Groblewska M,
Wereszczyńska-Siemiatkowska U, Okulczyk B, Kedra B, Łaszewicz W,
Dabrowski A and Szmitkowski M: Serum macrophage-colony stimulating
factor levels in colorectal cancer patients correlate with lymph
node metastasis and poor prognosis. Clin Chim Acta. 380:208–212.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Groblewska M, Mroczko B,
Wereszczyńska-Siemiatkowska U, Myśliwiec P, Kedra B and Szmitkowski
M: Serum levels of granulocyte colony-stimulating factor (G-CSF)
and macrophage colony-stimulating factor (M-CSF) in pancreatic
cancer patients. Clin Chem Lab Med. 45:30–34. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McDermott RS, Deneux L, Mosseri V,
Védrenne J, Clough K, Fourquet A, Rodriguez J, Cosset JM, Sastre X,
Beuzeboc P, et al: Circulating macrophage colony stimulating factor
as a marker of tumour progression. Eur Cytokine Netw. 13:121–127.
2002.PubMed/NCBI
|
|
36
|
Chambers SK, Kacinski BM, Ivins CM and
Carcangiu ML: Overexpression of epithelial macrophage
colony-stimulating factor (CSF-1) and CSF-1 receptor: A poor
prognostic factor in epithelial ovarian cancer, contrasted with a
protective effect of stromal CSF-1. Clin Cancer Res. 3:999–1007.
1997.PubMed/NCBI
|
|
37
|
Wang ZE, Myles GM, Brandt CS, Lioubin MN
and Rohrschneider L: Identification of the ligand-binding regions
in the macrophage colony-stimulating factor receptor extracellular
domain. Mol Cell Biol. 13:5348–5359. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Stein J, Borzillo GV and Rettenmier CW:
Direct stimulation of cells expressing receptors for macrophage
colony-stimulating factor (CSF-1) by a plasma membrane-bound
precursor of human CSF-1. Blood. 76:1308–1314. 1990.PubMed/NCBI
|
|
39
|
Hung JY, Chang WA, Tsai YM, Hsu YL, Chiang
HH, Chou SH, Huang MS and Kuo PL: Tricetin, a dietary flavonoid,
suppresses benzo(a)pyreneinduced human nonsmall cell lung cancer
bone metastasis. Int J Oncol. 46:1985–1993. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin EY, Nguyen AV, Russell RG and Pollard
JW: Colony-stimulating factor 1 promotes progression of mammary
tumors to malignancy. J Exp Med. 193:727–740. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu L, Liu W, Wang L, Zhu T, Zhong J and
Xie N: Hypoxia-inducible factor 1 mediates intermittent
hypoxia-induced migration of human breast cancer MDA-MB-231 cells.
Oncol Lett. 14:7715–7722. 2017.PubMed/NCBI
|
|
43
|
Chaturvedi P, Gilkes DM, Takano N and
Semenza GL: Hypoxia-inducible factor-dependent signaling between
triple-negative breast cancer cells and mesenchymal stem cells
promotes macrophage recruitment. Proc Natl Acad Sci USA.
111:E2120–E2129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao YT, Yan JY, Han XC, Niu FL, Zhang JH
and Hu WN: Anti-proliferative effect of digoxin on breast cancer
cells via inducing apoptosis. Eur Rev Med Pharmacol Sci.
21:5837–5842. 2017.PubMed/NCBI
|
|
45
|
Kothari S, Cizeau J, McMillan-Ward E,
Israels SJ, Bailes M, Ens K, Kirshenbaum LA and Gibson SB: BNIP3
plays a role in hypoxic cell death in human epithelial cells that
is inhibited by growth factors EGF and IGF. Oncogene. 22:4734–4744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lin A, Yao J, Zhuang L, Wang D, Han J, Lam
EW and Gan B: The FoxO-BNIP3 axis exerts a unique regulation of
mTORC1 and cell survival under energy stress. Oncogene.
33:3183–3194. 2014. View Article : Google Scholar : PubMed/NCBI
|
